Inventor
Ning Xi
Inventor
Thousand Oaks, CA, US
Overview
Patents· 59 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes21%
Y02ATechnologies for adaptation to climate change4%
C07CAcyclic or carbocyclic compounds3%
C07KPeptides2%
C07BGeneral methods of organic chemistry1%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C04BLime, magnesia1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
10,751,339Substituted aminopyrimidine compounds and methods of use202010,683,297Substituted heteroaryl compounds and methods of use202010,266,521Substituted heteroaryl compounds and methods of use201910,059,689Substituted heteroaryl compounds and methods of use20189,957,233Process for preparing substituted quinolin-4-ol compounds20189,938,257Substituted heteroaryl compounds and methods of use20189,926,324'Heteroaromatic compounds as PI3 kinase modulators and methods of use'20189,920,033'Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof'20189,718,841'Bicyclic pyrazolone compounds and methods of use'20179,695,150'Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof'20179,670,194'Substituted aminopyrimidine compounds and methods of use'20179,657,007'Substituted aminopyrimidine compounds and methods of use'20179,598,400'Substituted quinoline compounds and methods of use'20179,573,953'Heteroaromatic compounds as PI3 kinase modulators and methods of use'20179,518,046'Substituted aminopyrimidine compounds and methods of use'20169,512,114'Substituted aminopyrimidine compounds and methods of use'20169,403,801'Substituted heteroaryl compounds and methods of use'20169,399,639'Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use'20169,399,637'Substituted heteroaryl compounds and methods of use'20169,394,281'Substituted heteroaryl compounds and methods of use'20169,326,975'Substituted pyrazolone compounds and methods of use'20169,133,162'Substituted quinoline compounds and methods of use'20159,066,954'Fused heterocyclic derivatives and methods of use'20158,975,282'Substituted pyrazolone compounds and methods of use'20158,969,388'Substituted pyrazolone compounds and methods of use'20158,685,983'Method of treating cancer with substituted amide derivatives'20148,642,624'Substituted alkylamine derivatives and methods of use'20148,524,900'Fused heterocyclic derivatives and methods of use'20138,476,434'Protein kinase modulators and method of use'20138,426,585'Compounds comprising a spiro-ring'20138,349,831'Calcium receptor modulating agents'20138,314,087'Nitrogen-containing heterocyclyl ketones and methods of use'20128,293,897'Compounds comprising a spiro-ring and methods of use'20128,232,294'Amino ester derivatives, sailts thereof and methods of use'20128,178,557'Compounds and methods of use'20128,088,794'Substituted amide derivatives and methods of use'20128,026,241'Vanilloid receptor ligands and their use in treatments'20117,928,140'Benzothiazole PI3 kinase modulators for cancer treatment'20117,915,287'Substituted heterocycles and methods of use'20117,880,000'Protein kinase modulators and method of use'20117,652,009'Substituted heterocycles and methods of use'20107,626,030'Compounds and methods of use'20097,582,761'Vanilloid receptor ligands and their use in treatments'20097,560,460'Substituted piperazines and methods of use'20097,524,873'Calcium receptor modulating agents'20097,514,564'Substituted amine derivatives and methods of use'20097,439,360'Vanilloid receptor ligands and their use in treatments'20087,435,823'Compounds and methods of use'20087,265,138'Vanilloid receptor ligands and their use in treatments'20077,196,102'Calcium receptor modulating agents'20077,176,322'Calcium receptor modulating agents'20077,115,607'Substituted piperazinyl amides and methods of use'20067,105,682'Substituted amine derivatives and methods of use'20067,101,868'Substituted arylamine derivatives and methods of use'20066,995,162'Substituted alkylamine derivatives and methods of use'20066,977,264'Substituted piperidines and methods of use'20056,908,935'Calcium receptor modulating agents'20056,878,714'Substituted alkylamine derivatives and methods of use'20056,849,639'Integrin inhibitors and their methods of use'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2015Patents assigned to AMGEN INC (32)· patent assignee history
2005–2015Based in Thousand Oaks, CA, US· patent location history
2012–2020Patents assigned to SUNSHINE LAKE PHARMA CO LTD (27)· patent assignee history
2012–2017Patents assigned to XI NING (13)· patent assignee history
2012–2014Patents assigned to BOOKER SHON (6)· patent assignee history
2013–2020Based in Newbury Park, CA, US· patent location history
2015–2020Patents assigned to CALITOR SCIENCES LLC (24)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 32 | 2005–2015 |
| SUNSHINE LAKE PHARMA CO LTD | 27 | 2012–2020 |
| CALITOR SCIENCES LLC | 24 | 2015–2020 |
| XI NINGself | 13 | 2012–2017 |
| BOOKER SHON | 6 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Thousand Oaks, California, US | 34 | 2005–2015 |
| Newbury Park, California, US | 25 | 2013–2020 |